Literature DB >> 6527243

Characterization of drug-loaded poly(d,l-lactide) microspheres.

S Benita, J P Benoit, F Puisieux, C Thies.   

Abstract

Lomustine and progesterone have been incorporated in biodegradable poly(d,l-lactide) microspheres by evaporating dichloromethane from stirred dichloromethane-in-water emulsions. Spherical microspheres with lomustine or progesterone payloads less than or equal to 23% were obtained. Higher lomustine payloads gave irregularly shaped particles. Microspheres with less than or equal to 68% progesterone were obtained, but free drug crystals formed on the surface of such microspheres. Increased agitation rates decreased mean microsphere size. Addition of drug to the dichloromethane phase increased average particle size relative to that obtained with drug-free microspheres prepared under the same experimental conditions. Complete evaporation of the dichloromethane, while the medium was continuously stirred, promoted formation of free drug crystals in the aqueous phase. Increased emulsifier concentrations did not significantly enhance drug incorporation efficiency within the microspheres. Shelf-life stability of lomustine and progesterone was reduced by incorporation in the microspheres, presumably due to their molecular dispersion in the poly(d,l-lactide).

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6527243     DOI: 10.1002/jps.2600731215

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  12 in total

1.  An investigation into the surface deposition of progesterone on poly (d,l-) lactic acid microspheres using micro-thermal analysis.

Authors:  P G Royall; V L Hill; D Q Craig; D M Price; M Reading
Journal:  Pharm Res       Date:  2001-03       Impact factor: 4.200

2.  Microencapsulation of solid dispersions: release of griseofulvin from griseofulvin:phospholipid coprecipitates in microspheres.

Authors:  G K Vudathala; J A Rogers
Journal:  Pharm Res       Date:  1992-06       Impact factor: 4.200

3.  Microencapsulation of hepatitis B core antigen for vaccine preparation.

Authors:  T Uchida; K Shiosaki; Y Nakada; K Fukada; Y Eda; S Tokiyoshi; N Nagareya; K Matsuyama
Journal:  Pharm Res       Date:  1998-11       Impact factor: 4.200

4.  Optimization of DNA delivery by three classes of hybrid nanoparticle/DNA complexes.

Authors:  Qiu Zhong; Dakshina Murthy Devanga Chinta; Sarala Pamujula; Haifan Wang; Xin Yao; Tarun K Mandal; Ronald B Luftig
Journal:  J Nanobiotechnology       Date:  2010-02-24       Impact factor: 10.435

5.  Production of 5-15 microns diameter alginate-polylysine microcapsules by an air-atomization technique.

Authors:  K K Kwok; M J Groves; D J Burgess
Journal:  Pharm Res       Date:  1991-03       Impact factor: 4.200

6.  Porous biodegradable microspheres for controlled drug delivery. I. Assessment of processing conditions and solvent removal techniques.

Authors:  T Sato; M Kanke; H G Schroeder; P P DeLuca
Journal:  Pharm Res       Date:  1988-01       Impact factor: 4.200

7.  New Method to Prepare Mitomycin C Loaded PLA-Nanoparticles with High Drug Entrapment Efficiency.

Authors:  Zhenqing Hou; Heng Wei; Qian Wang; Qian Sun; Chunxiao Zhou; Chuanming Zhan; Xiaolong Tang; Qiqing Zhang
Journal:  Nanoscale Res Lett       Date:  2009-04-21       Impact factor: 4.703

8.  Relation between individual and ensemble release kinetics of indomethacin from microspheres.

Authors:  S Benita; D Babay; A Hoffman; M Donbrow
Journal:  Pharm Res       Date:  1988-03       Impact factor: 4.200

9.  Dynamic changes in size distribution of emulsion droplets during ethyl acetate-based microencapsulation process.

Authors:  Y Bahl; H Sah
Journal:  AAPS PharmSciTech       Date:  2000-03-23       Impact factor: 3.246

10.  Structural analysis of microparticles by confocal laser scanning microscopy.

Authors:  A Lamprecht; U Schäfer; C M Lehr
Journal:  AAPS PharmSciTech       Date:  2000-06-23       Impact factor: 3.246

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.